| dc.contributor.author | van den Belt, Sophie M. | |
| dc.contributor.author | Schaefer, Franz | |
| dc.contributor.author | Querfeld, Uwe | |
| dc.contributor.author | Melk, Anette | |
| dc.contributor.author | de Zeeuw, Dick | |
| dc.contributor.author | Wuehl, Elke | |
| dc.contributor.author | Gellermann, Jutta | |
| dc.contributor.author | ERDOĞAN, HAKAN | |
| dc.contributor.author | Fidan, Kibriya | |
| dc.contributor.author | ÖZÇAKAR, ZEYNEP BİRSİN | |
| dc.contributor.author | Paripovic, Dusan | |
| dc.contributor.author | Shroff, Rukshana | |
| dc.contributor.author | Bacchetta, Justine | |
| dc.contributor.author | DÜZOVA, ALİ | |
| dc.contributor.author | Azukaitis, Karolis | |
| dc.contributor.author | KAPLAN BULUT, İPEK | |
| dc.contributor.author | CANPOLAT, Nur | |
| dc.contributor.author | Niemirska, Anna | |
| dc.contributor.author | KARABAY BAYAZIT, AYSUN | |
| dc.contributor.author | Thurn-Valsassina, Daniela | |
| dc.contributor.author | Gracchi, Valentina | |
| dc.contributor.author | Kirchner, Marietta | |
| dc.contributor.author | Heerspink, Hiddo J. L. | |
| dc.date.accessioned | 2021-03-02T18:31:06Z | |
| dc.date.available | 2021-03-02T18:31:06Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | van den Belt S. M. , Heerspink H. J. L. , Kirchner M., Gracchi V., Thurn-Valsassina D., KARABAY BAYAZIT A., Niemirska A., CANPOLAT N., KAPLAN BULUT İ., Azukaitis K., et al., "Discontinuation of RAAS Inhibition in Children with Advanced CKD", CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, cilt.15, sa.5, ss.625-632, 2020 | |
| dc.identifier.issn | 1555-9041 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_7904e8f8-0125-405d-b8a8-644d281f29e4 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/5065 | |
| dc.identifier.uri | https://doi.org/10.2215/cjn.09750819 | |
| dc.description.abstract | Background and objectives Although renin-angiotensin-aldosterone system inhibition (RAASi) is a cornerstone in the treatment of children with CKD, it is sometimes discontinued when kidney function declines. We studied the reasons of RAASi discontinuation and associations between RAASi discontinuation and important risk markers of CKD progression and on eGFR decline in the Cardiovascular Comorbidity in Children with CKD study. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Nefroloji | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | ÜROLOJİ VE NEFROLOJİ | |
| dc.title | Discontinuation of RAAS Inhibition in Children with Advanced CKD | |
| dc.type | Makale | |
| dc.relation.journal | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | |
| dc.contributor.department | University of Groningen , , | |
| dc.identifier.volume | 15 | |
| dc.identifier.issue | 5 | |
| dc.identifier.startpage | 625 | |
| dc.identifier.endpage | 632 | |
| dc.contributor.firstauthorID | 2281779 | |